Fewer complications for patients with leadless pacemakers

A research study found that patients with leadless pacemakers are likely to have fewer short-term and mid-term complications than those with transvenous pacemakers. Approximately a million pacemakers are annually implanted in patients to provide electrical stimulation to regulate heartbeat. Conventional pacemakers are surgically placed under the skin of patient’s chest stretching from the shoulder vein…

Cardiovascular disease: Study finds best drugs for prevention

A large cohort study has identified which treatment combinations work best for people with high blood pressure who are at risk of heart disease. Taking both blood pressure drugs and statins might be the best choice, the researchers find. Researchers from the William Harvey Research Institute at Queen Mary University London in the United Kingdom…

Not Smoking, Managing Blood Glucose Dramatically Reduce Heart Risk for Diabetes Patients

“This is definitely good news. The study shows that patients with type 2 diabetes with all risk factors within therapeutic target range had an extremely low risk of premature death, heart attack and stroke,” says Aidin Rawshani, medical intern and doctoral student at the Institute of Medicine, Sahlgrenska Academy, Sweden, and author of the article….

US approves MSD HIV drugs Delstrigo and Pifeltro

Delstrigo is a once-daily fixed-dose combination tablet of doravirine, lamivudine and tenofovir disoproxil fumarate, while Pifeltro is a new non-nucleoside reverse transcriptase inhibitor (NNRTI) to be administered in combination with other antiretroviral medicines. In DRIVE-AHEAD trial, 728 participants with no antiretroviral treatment history were randomized and received at least one dose of either Delstrigo or…